arrow
K

Kirsten D. Mertz

university of basel
H指数:48
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer

肺癌中细胞毒性CD39<sup>+</sup>肿瘤相关NK细胞对NKG2A阻断的反应

2026-06-050
PRE
Unbiased DNA pathogen detection in tissues: Real-world experience with metagenomic sequencing in pathology

组织中无偏倚的DNA病原体检测:病理学中元基因组测序的实际经验

2025-10-290
OAAI
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer

病理学家式可解释AI用于前列腺癌可解释的Gleason分级

2025-10-080
OAAI
Single-cell analysis uncovers preserved prostate cancer lineages and universally altered pathways in Matrigel-free patient-derived organoids

单细胞分析揭示了无Matrigel患者来源类器官中保留的前列腺癌谱系和普遍改变的通路

2025-09-300
OAAI
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis

基于深度学习的结直肠癌肿瘤纯度评估及其对分子分析的影响

2024-12-220
OA
Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology

报告临床癌症护理中的体细胞变异: 瑞士分子病理学会的建议

2024-10-230
OAAI
Swiss digital pathology recommendations: results from a Delphi process conducted by the Swiss Digital Pathology Consortium of the Swiss Society of Pathology
2023-12-192
OAAI
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

欧洲胸部病理学实验室对非小细胞肺癌的真实世界EGFR测试实践

2023-10-0112
OAAI
Bone marrow haematopoiesis in patients with COVID-19
2023-06-140
OA
Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer

烟酰胺N-甲基转移酶维持促进乳腺癌转移性定植的核心表观遗传程序

2023-06-0111
OA